Independent scientific counsel for programs moving from mechanism to the clinic.
Independent scientific counsel for programs moving from mechanism to the clinic.
Identifying and validating novel targets grounded in human biology data — human genetics, multi-omics, and patient-derived evidence — to build a defensible mechanistic case before a program moves forward.
Mechanism-driven program design and IND-enabling strategy — bridging preclinical insight and first-in-human decisions through translational medicine, with a clear line of scientific reasoning at every step.
Assay strategy, biomarker qualification, and data interpretation that de-risk clinical decisions from Phase 1 through registration — including central lab selection, kit build and validation, clinical pharmacology and PK/PD modeling, diagnostic and companion diagnostic development, and the operational logistics that keep biomarker data trial-ready.
Regulatory advice from a biomarker and diagnostic development standpoint — assay and companion diagnostic regulatory strategy, agency interactions, and evidence packages built to align biomarker data with its intended clinical use.
Banba Scientific is an independent consulting practice built on more than fifteen years in drug discovery and development, spanning neurodegenerative disease, rare immune disorders, and hepatic conditions.